Management and Healthcare Utilization of Patients With COPD and Asthma During the COVID-19 Epidemic in Beijing
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Pulmonary Disease, Chronic Obstructive
- Sponsor
- Peking University Third Hospital
- Enrollment
- 153
- Locations
- 1
- Primary Endpoint
- Frequency of exacerbation during the COVID-19 epidemic
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
During the COVID-19 epidemic, the medical treatment, disease status, and medication status of patients with chronic airway disease have not been studied. The purpose of this study is to investigate the management and healthcare utilization of patients with chronic airway disease and the influencing factors during the COVID-19 epidemic.
Detailed Description
During the COVID-19 epidemic, the medical treatment, disease status, and medication status of patients with chronic airway disease have not been studied. The purpose of this study is to investigate the management and healthcare utilization of patients with chronic airway disease and the relevant factors during the COVID-19 epidemic. Using cross-sectional research methods, telephone interviews and questionnaire surveys were used to investigate the management and healthcare utilization of patients with chronic airway disease （COPD and asthma）during the COVID-19 epidemic.
Investigators
Sun Yongchang
Head of Respiratory and Critical Care Medicine
Peking University Third Hospital
Eligibility Criteria
Inclusion Criteria
- •COPD patients and asthma patients in the Chronic Airway Disease Database in Peking University Third Hospital.
Exclusion Criteria
- •Refusal to participate in this study; cognitive dysfunction.
Outcomes
Primary Outcomes
Frequency of exacerbation during the COVID-19 epidemic
Time Frame: through study completion, an average of 2 week.
Frequency of exacerbation during the COVID-19 epidemic
Respiratory symptoms
Time Frame: through study completion, an average of 2 week.
COPD Assessment Test (CAT)